| HOME >> BIOLOGY >> TECHNOLOGY |
VIROPHARMA INCORPORATED
Selected Financial Information
Consolidated Statements of Three months Twelve months
Operations: ended ended
December 31, December 31,
(in thousands, except per ----------- -----------
share data) 2008 2007 2008 2007
---- ---- ---- ----
Revenue:
Net product sales $50,020 $47,696 $232,307 $203,770
------ ------ ------- -------
Revenue 50,020 47,696 232,307 203,770
------ ------ ------- -------
Costs and Expenses:
Cost of sales (excluding
amortization of product rights) 2,110 2,034 8,874 8,934
Research and development 21,197 12,504 66,280 35,869
Selling, general and
administrative 22,357 12,710 65,424 37,051
Intangible amortization 5,505 1,401 10,809 6,120
Impairment of fixed assets
held for sale 2,265 - 2,265 -
'/>"/>
| SOURCE ViroPharma, Inc. Copyright©2009 PR Newswire. All rights reserved |